Manufacturing Associate 1
Kincell Bio
Manufacturing Associate 1
Kincell Bio
Cell therapy CDMO: development, CMC, manufacturing
Kincellis Advanced Therapies is a U.S.-based contract development and manufacturing organization supporting advanced-therapy developers from early-stage CMC, process and analytical development through clinical supply, pivotal-stage programs and commercial supply. With facilities in Gainesville, Florida; Research Triangle Park, North Carolina; and The Woodlands, Texas, Kincellis combines broad technical expertise with flexible, scalable GMP infrastructure across autologous and allogeneic therapies, including but not limited to CAR-T, Tregs, CAR-NK, MSCs, dendritic cell vaccines, exosomes, iPSCs & synthetic mRNA.
For more information, visit our website at www.kincellis.com.
As a Contingent Manufacturing Associate I, you will be responsible for operating both automated and manual cell therapy equipment of varying complexity to support CAR-T, CAR-M, or CAR-NK manufacturing processes, following established standard operating procedures and company policies. You will conduct quality control analyses to support in-process batch production and detect any process deviations. This role involves handling leukapheresis-derived cellular materials; therefore, you will receive comprehensive training in hazardous material handling and emergency response procedures.
As part of the manufacturing operations, you will be expected to demonstrate a strong understanding of procedures, techniques, tools, materials, and equipment used in the production process. Your role will involve team-based decision-making, with a focus on prioritizing workflows based on process requirements and available resources. You will follow standard operating procedures to carry out tasks that may vary in scope, complexity, and duration.
Patients are counting on dedicated professionals like you—those who take pride in their work and strive for meaningful results. In this role, you'll play a vital part in ensuring life-changing therapies reach the patients who need them, exactly when they need them most!
Essential Duties and Responsibilities
Reasonable accommodations may be made to enable individuals with disabilities to perform the essential functions of this position.This list contains the major duties and requirements of the job and is not all-inclusive. Incumbent(s) may be expected to perform role-related duties other than those contained in this document.
Qualifications
The requirements listed below are representative of the knowledge, skill, and/or ability required to perform this job successfully.
Required:
Preferred:
Travel Requirements
Location
#LI-Onsite
Kincellis Advanced Therapies provides equal employment opportunities (EEO) to all employees and applicants for employment without regard to race, color, religion, gender, sexual orientation, gender identity or expression, national origin, age, disability, genetic information, marital status, amnesty, or status as a covered veteran in accordance with applicable, federal, state, and local laws. Kincellis Advanced Therapies complies with applicable state and local laws governing non-discrimination in employment in every location in which the company has facilities. This policy applies to all terms and conditions of employment, including, but not limited to, hiring, placement, promotion, termination, layoff, recall, transfer, leaves of absence, compensation, and training.
NOTE TO EMPLOYMENT AGENCIES: Kincellis Advanced Therapies values our relationships with our Recruitment Partners. We will only accept resumes from those partners who have been contracted by a member of our Human Resources team to collaborate with us. We are not responsible for any fees related to resumes that are unsolicited or are received without contract.
Cell therapy CDMO: development, CMC, manufacturing
Kincell Bio is a CDMO that specializes in cell therapies, offering end-to-end development and manufacturing services for early-stage biotech companies and academic spinouts. It provides analytical development, process development, CMC consulting, and GMP manufacturing to advance autologous and allogeneic CAR-T, CAR-NK, and CAR-M programs from research through clinical trials. Led by experienced CDMO executives and supported by investors, it focuses on early-stage partnerships and has expanded capacity with a new RTP facility to scale mid- to late-stage studies. Its goal is to streamline the path from research to clinical trials and commercial production by delivering scalable, high-quality biomanufacturing and development services for the cell-therapy field.
Explore more opportunities at Kincell Bio